Bronchodilator Response in 4-12 Years Chinese Controller Naive Asthmatic Children
NCT ID: NCT01500525
Last Updated: 2021-09-28
Study Results
Results available
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Total Enrollment
587 participants
Study Classification
OBSERVATIONAL
Study Start Date
2011-12-31
Study Completion Date
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives:
1. To observe BDR distribution curve for Chinese non-asthmatic and controller-naïve asthmatic children from 4-12 years respectively
2. To compare BDR values between non-asthmatic group and controller-naïve asthmatic group, and analyze appropriate cut-off point value
Background and rationale:
According to the guidelines spirometry, including baseline forced expiratory volume in 1 second (FEV1) and the bronchodilator response (BDR) to short acting beta agonists (SABA), should be used in children as objective measures to establish the diagnosis and severity of bronchial asthma. Baseline FEV1 is usually in the normal range (greater than 80% predicted) in children, regardless of asthma severity, so several other objective measures have been suggested for diagnosis in children, including the response to a bronchodilator, which reflects airway reversibility.
The current definition for a positive BDR is \>12% reversibility. In the study carried out by Galant et al among 51 non-asthmatic children and 346 controller naïve asthmatic children between 4-17 years, the BDR value could achieve 12% in only 30.6% asthmatic children, across all severity. Also, in a study among 142 children between 5-10 years in UK, 9% increase in FEV1 after bronchodilator use was suggested as the cutoff point with good sensitivity and specificity.
Difference between the proposed study to be carried out in our hospital and the one in Anhui Province is that we will tentatively calculate a BDR cutoff point by using receiver operating characteristic (ROC curve). And the cutoff point can be used as a reference indicator in asthma diagnosis and long-term management.
The current BDR cutoff point of 12% that is not ideal for children can also be reflected in the clinical management. It has been shown that a persistent BDR value, even less than 12%, in asthmatic children suggests poor clinical outcome. In a 4 years study among 1041 asthmatic children in America carried out by Sharma et al, it showed that compared with individuals who had a BDR of 12% and 200ml, individuals who had a BDR of 10% had similar poor clinical outcomes (e.g. more hospital visits, more prednisone bursts, increased nocturnal awakenings, and missing more days of school). Same results were also obtained in Galant et al study among 679 asthmatic children among 5-18 years.
1. To observe BDR distribution curve for Chinese non-asthmatic and controller-naïve asthmatic children from 4-12 years respectively
2. To compare BDR values between non-asthmatic group and controller-naïve asthmatic group, and analyze appropriate cut-off point value
Background and rationale:
According to the guidelines spirometry, including baseline forced expiratory volume in 1 second (FEV1) and the bronchodilator response (BDR) to short acting beta agonists (SABA), should be used in children as objective measures to establish the diagnosis and severity of bronchial asthma. Baseline FEV1 is usually in the normal range (greater than 80% predicted) in children, regardless of asthma severity, so several other objective measures have been suggested for diagnosis in children, including the response to a bronchodilator, which reflects airway reversibility.
The current definition for a positive BDR is \>12% reversibility. In the study carried out by Galant et al among 51 non-asthmatic children and 346 controller naïve asthmatic children between 4-17 years, the BDR value could achieve 12% in only 30.6% asthmatic children, across all severity. Also, in a study among 142 children between 5-10 years in UK, 9% increase in FEV1 after bronchodilator use was suggested as the cutoff point with good sensitivity and specificity.
Difference between the proposed study to be carried out in our hospital and the one in Anhui Province is that we will tentatively calculate a BDR cutoff point by using receiver operating characteristic (ROC curve). And the cutoff point can be used as a reference indicator in asthma diagnosis and long-term management.
The current BDR cutoff point of 12% that is not ideal for children can also be reflected in the clinical management. It has been shown that a persistent BDR value, even less than 12%, in asthmatic children suggests poor clinical outcome. In a 4 years study among 1041 asthmatic children in America carried out by Sharma et al, it showed that compared with individuals who had a BDR of 12% and 200ml, individuals who had a BDR of 10% had similar poor clinical outcomes (e.g. more hospital visits, more prednisone bursts, increased nocturnal awakenings, and missing more days of school). Same results were also obtained in Galant et al study among 679 asthmatic children among 5-18 years.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Investigate the Prevalence of Children Asthma in China
NCT01319292
Asthma
COMPLETED
Patients' Compliance to Home Nebulizer Therapy for Children's Asthma in China
NCT03156998
Paediatric Asthma
COMPLETED
Clinical Characteristics of Severe Childhood Asthma
NCT06024902
Severe Asthma
COMPLETED
Children-Adult Asthma Cohort Study in China
NCT03046433
Asthma in Children
UNKNOWN
Control and Treatment of Outpatient Children with Asthma
NCT06837584
Asthma
NOT_YET_RECRUITING
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a prospective observational non-interventional clinical study.
1. Patient population:
300 non-asthmatic and 300 asthmatic children will be recruited.
1. Non-asthmatic group: healthy children from 4-12 years will be recruited from the Capital Institute of Pediatrics nearby schools
Inclusion criteria:
1\) Willingly attend this investigation 2) Chest physical tests are normal
Exclusion criteria:
1\) The child had been hospitalized for any severe respiratory condition 2) A physician had ever stated that the child had asthma, reactive airway diseases, or the child had taken antiasthma medications for symptoms 3) The child was diagnosed with congenital heart disease requiring surgery or medications for management 4) There are positive responses concerning other serious chest problems, chest surgery, chronic productive cough, recurrent intractable wheezing, and shortness of breath 5) The children can not finish the test that met American Thoracic Society criteria for preschool children in a maximum of 6 attempts and are unable to successfully complete post-bronchodilator (BD) spirometry
2. Asthmatic group: 4-12 years old asthmatic children will be recruited from the asthma clinic of the Capital Institute of Pediatrics
Inclusion criteria:
1\) Diagnose asthma by specialist of asthma (based on symptoms): criteria for the diagnosis of asthma made by the asthma specialist included a history of recurrent coughing, wheezing, or shortness of breath at rest or with exercise, symptomatic improvement after bronchodilator use, and exclusion of other diagnoses 2) Asymptomatic or mild symptomatic with no physical signs of wheeze at the time of testing 3) Not receiving controller medication 6 weeks prior to the initial evaluation 4) Willing to attend this investigation
Exclusion criteria:
1. Using short β2 agonists within 6 hours
2. Using long acting β2 agonists within 24 hours
3. Can not finish the test that met American Thoracic Society criteria for preschool children in a maximum of 6 attempts and are unable to successfully complete post-bronchodilator spirometry.
2\. Preparation before tests
1. Sign the consent form.
2. Fill the asthma severity form according to NEAPP guideline (asthmatic group).
3. Chest physical test, record on the form of test.
4. Standing height and weight will be measured.
5. Calculation of age: The date of test subtracts the date of birth.
3\. Pulmonary function tests
Standardized pulmonary function tests will be conducted.
Contents of tests:
Pre and post flow volume: forced volume vital capacity (FVC), FEV0.5, FEV1, FEV1/FVC ratio, PEF, forced expiratory flow 25 (FEF25), FEF50, FEF75, FEF25-75, forced expiratory time (FET), back-extrapolated volume (VBE), VBE/FVC.
The BDR is based on pulmonary function measurements before and after administration of 2.5 mg albuterol by nebulizer. BDR is calculated as \[(postbronchodilator FEV1- baseline FEV1)/baseline FEV1\] x 100%.
Study Procedures:
1\. Spirometry preparation The spirometry was purchased from VIASYS Healthcare, Hochberg Germany (MasterScope).
1. Check: Before switch on, check the conjunction between flow sensor and the hand knob, ensure that the black compact is tightness.
2. Calibration: Before calibration, the room temperature, pressure, humidity should be tested and recorded and all of the parameter should be reconciled to BTPS condition.
Using 2 liters scalar to calibrate flow. Every day do the even flow calibration. Every week do the flow linear calibration, include high, media and low flow these three different flow calibration. The variety should be less than 3%.
The record of calibration should be printed, and the technician should be signed on it and save it.
2\. Test method The training process is the same as Eigen H. et al (ref 8). The entire instruction and testing session for each child is strictly limited to 15 min, during which time children are instructed in the techniques of spirometry and performed at least three forced vital capacity maneuvers. A highly experienced children's pulmonary function technologist does the instruction for each child. At the time of testing, each child is given an explanation of the testing procedure individually and then tested using coaching techniques used in our pulmonary function laboratory in evaluating younger children.
3\. Criteria for accepting Data (ATS/ERS 2005) The principles of spirometry quality control in preschool children are the same as for adults.
1. It is necessary to visually inspect the flow-volume and volume-time traces, and exclude maneuvers that are visibly inadequate. Maneuvers should be excluded if the flow-volume curve does not demonstrate a rapid rise to peak flow, or a smooth descending limb, with no evidence of cough or glottis closure.
2. The start of test should be quantified by calculating the VBE. Some investigators reported that more than 80% of the studied preschool population achieved a VBE of less than or equal to 80 ml or less than 12.5% of the FVC. Alternative criteria are presented, but these should be viewed as a guide to assist visual inspection, rather than as exclusion criteria.
3. The end of test should be quantified by reporting the point of cessation of flow. It is known that many preschool children cannot sustain forced expiration for 1 second, let alone the 6 seconds previously stipulated for adults (ref 9) , and the forced expired time should be reported but should not be used to exclude maneuvers. This pattern should not be misinterpreted as early termination (ref 10).
1. Patient population:
300 non-asthmatic and 300 asthmatic children will be recruited.
1. Non-asthmatic group: healthy children from 4-12 years will be recruited from the Capital Institute of Pediatrics nearby schools
Inclusion criteria:
1\) Willingly attend this investigation 2) Chest physical tests are normal
Exclusion criteria:
1\) The child had been hospitalized for any severe respiratory condition 2) A physician had ever stated that the child had asthma, reactive airway diseases, or the child had taken antiasthma medications for symptoms 3) The child was diagnosed with congenital heart disease requiring surgery or medications for management 4) There are positive responses concerning other serious chest problems, chest surgery, chronic productive cough, recurrent intractable wheezing, and shortness of breath 5) The children can not finish the test that met American Thoracic Society criteria for preschool children in a maximum of 6 attempts and are unable to successfully complete post-bronchodilator (BD) spirometry
2. Asthmatic group: 4-12 years old asthmatic children will be recruited from the asthma clinic of the Capital Institute of Pediatrics
Inclusion criteria:
1\) Diagnose asthma by specialist of asthma (based on symptoms): criteria for the diagnosis of asthma made by the asthma specialist included a history of recurrent coughing, wheezing, or shortness of breath at rest or with exercise, symptomatic improvement after bronchodilator use, and exclusion of other diagnoses 2) Asymptomatic or mild symptomatic with no physical signs of wheeze at the time of testing 3) Not receiving controller medication 6 weeks prior to the initial evaluation 4) Willing to attend this investigation
Exclusion criteria:
1. Using short β2 agonists within 6 hours
2. Using long acting β2 agonists within 24 hours
3. Can not finish the test that met American Thoracic Society criteria for preschool children in a maximum of 6 attempts and are unable to successfully complete post-bronchodilator spirometry.
2\. Preparation before tests
1. Sign the consent form.
2. Fill the asthma severity form according to NEAPP guideline (asthmatic group).
3. Chest physical test, record on the form of test.
4. Standing height and weight will be measured.
5. Calculation of age: The date of test subtracts the date of birth.
3\. Pulmonary function tests
Standardized pulmonary function tests will be conducted.
Contents of tests:
Pre and post flow volume: forced volume vital capacity (FVC), FEV0.5, FEV1, FEV1/FVC ratio, PEF, forced expiratory flow 25 (FEF25), FEF50, FEF75, FEF25-75, forced expiratory time (FET), back-extrapolated volume (VBE), VBE/FVC.
The BDR is based on pulmonary function measurements before and after administration of 2.5 mg albuterol by nebulizer. BDR is calculated as \[(postbronchodilator FEV1- baseline FEV1)/baseline FEV1\] x 100%.
Study Procedures:
1\. Spirometry preparation The spirometry was purchased from VIASYS Healthcare, Hochberg Germany (MasterScope).
1. Check: Before switch on, check the conjunction between flow sensor and the hand knob, ensure that the black compact is tightness.
2. Calibration: Before calibration, the room temperature, pressure, humidity should be tested and recorded and all of the parameter should be reconciled to BTPS condition.
Using 2 liters scalar to calibrate flow. Every day do the even flow calibration. Every week do the flow linear calibration, include high, media and low flow these three different flow calibration. The variety should be less than 3%.
The record of calibration should be printed, and the technician should be signed on it and save it.
2\. Test method The training process is the same as Eigen H. et al (ref 8). The entire instruction and testing session for each child is strictly limited to 15 min, during which time children are instructed in the techniques of spirometry and performed at least three forced vital capacity maneuvers. A highly experienced children's pulmonary function technologist does the instruction for each child. At the time of testing, each child is given an explanation of the testing procedure individually and then tested using coaching techniques used in our pulmonary function laboratory in evaluating younger children.
3\. Criteria for accepting Data (ATS/ERS 2005) The principles of spirometry quality control in preschool children are the same as for adults.
1. It is necessary to visually inspect the flow-volume and volume-time traces, and exclude maneuvers that are visibly inadequate. Maneuvers should be excluded if the flow-volume curve does not demonstrate a rapid rise to peak flow, or a smooth descending limb, with no evidence of cough or glottis closure.
2. The start of test should be quantified by calculating the VBE. Some investigators reported that more than 80% of the studied preschool population achieved a VBE of less than or equal to 80 ml or less than 12.5% of the FVC. Alternative criteria are presented, but these should be viewed as a guide to assist visual inspection, rather than as exclusion criteria.
3. The end of test should be quantified by reporting the point of cessation of flow. It is known that many preschool children cannot sustain forced expiration for 1 second, let alone the 6 seconds previously stipulated for adults (ref 9) , and the forced expired time should be reported but should not be used to exclude maneuvers. This pattern should not be misinterpreted as early termination (ref 10).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Asthma
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Observational Model Type
CASE_CONTROL
Study Time Perspective
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
asthmatic children
children diagnosed by a specialist as asthmatic patients
No interventions assigned to this group
non-asthmatic children
children who are healthy and who do not have respiratory syndrom
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Willingly attend this investigation
2. Chest physical tests are normal
1. Diagnose asthma by specialist of asthma (based on symptoms): criteria for the diagnosis of asthma made by the asthma specialist included a history of recurrent coughing, wheezing, or shortness of breath at rest or with exercise, symptomatic improvement after bronchodilator use, and exclusion of other diagnoses
2. Asymptomatic or mild symptomatic with no physical signs of wheeze at the time of testing
3. Not receiving controller medication 6 weeks prior to the initial evaluation
4. Willing to attend this investigation
2. Chest physical tests are normal
1. Diagnose asthma by specialist of asthma (based on symptoms): criteria for the diagnosis of asthma made by the asthma specialist included a history of recurrent coughing, wheezing, or shortness of breath at rest or with exercise, symptomatic improvement after bronchodilator use, and exclusion of other diagnoses
2. Asymptomatic or mild symptomatic with no physical signs of wheeze at the time of testing
3. Not receiving controller medication 6 weeks prior to the initial evaluation
4. Willing to attend this investigation
Exclusion Criteria
1. The child had been hospitalized for any severe respiratory condition
2. A physician had ever stated that the child had asthma, reactive airway diseases, or the child had taken antiasthma medications for symptoms
3. The child was diagnosed with congenital heart disease requiring surgery or medications for management
4. There are positive responses concerning other serious chest problems, chest surgery, chronic productive cough, recurrent intractable wheezing, and shortness of breath
5. The children can not finish the test that met American Thoracic Society criteria for preschool children in a maximum of 6 attempts and are unable to successfully complete post-bronchodilator (BD) spirometry
* Asthmatic group: 4-12 years old asthmatic children will be recruited from the asthma clinic of the Capital Institute of Pediatrics
1. Using short β2 agonists within 6 hours
2. Using long acting β2 agonists within 24 hours
3. Can not finish the test that met American Thoracic Society criteria for preschool children in a maximum of 6 attempts and are unable to successfully complete post-bronchodilator spirometry.
2. A physician had ever stated that the child had asthma, reactive airway diseases, or the child had taken antiasthma medications for symptoms
3. The child was diagnosed with congenital heart disease requiring surgery or medications for management
4. There are positive responses concerning other serious chest problems, chest surgery, chronic productive cough, recurrent intractable wheezing, and shortness of breath
5. The children can not finish the test that met American Thoracic Society criteria for preschool children in a maximum of 6 attempts and are unable to successfully complete post-bronchodilator (BD) spirometry
* Asthmatic group: 4-12 years old asthmatic children will be recruited from the asthma clinic of the Capital Institute of Pediatrics
1. Using short β2 agonists within 6 hours
2. Using long acting β2 agonists within 24 hours
3. Can not finish the test that met American Thoracic Society criteria for preschool children in a maximum of 6 attempts and are unable to successfully complete post-bronchodilator spirometry.
Minimum Eligible Age
4 Years
Maximum Eligible Age
12 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Merck Sharp & Dohme LLC
INDUSTRY
Sponsor Role
collaborator
Capital Institute of Pediatrics, China
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
caoling
Director of Pulmonary Department, Director of Asthma Center
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ling Cao, MD
Role: PRINCIPAL_INVESTIGATOR
Capital Institute of Pediatrics, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Capital Institute of Pediatrics
Beijing, Beijing Municipality, China
Site Status
Countries
Review the countries where the study has at least one active or historical site.
China
References
Explore related publications, articles, or registry entries linked to this study.
Bacharier LB, Strunk RC, Mauger D, White D, Lemanske RF Jr, Sorkness CA. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med. 2004 Aug 15;170(4):426-32. doi: 10.1164/rccm.200308-1178OC. Epub 2004 Jun 1.
Reference Type
RESULT
Kumar R, Wang B, Wang X, Chen C, Yang J, Fu L, Xu X. Bronchodilator responses in Chinese children from asthma index families and the general population. J Allergy Clin Immunol. 2006 Jun;117(6):1257-63. doi: 10.1016/j.jaci.2006.02.049.
Reference Type
RESULT
Galant SP, Morphew T, Amaro S, Liao O. Value of the bronchodilator response in assessing controller naive asthmatic children. J Pediatr. 2007 Nov;151(5):457-62, 462.e1. doi: 10.1016/j.jpeds.2007.05.004.
Reference Type
RESULT
Dundas I, Chan EY, Bridge PD, McKenzie SA. Diagnostic accuracy of bronchodilator responsiveness in wheezy children. Thorax. 2005 Jan;60(1):13-6. doi: 10.1136/thx.2004.029934.
Reference Type
RESULT
Sharma S, Litonjua AA, Tantisira KG, Fuhlbrigge AL, Szefler SJ, Strunk RC, Zeiger RS, Murphy AJ, Weiss ST; Childhood Asthma Management Program Research Group. Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program. J Allergy Clin Immunol. 2008 Nov;122(5):921-928.e4. doi: 10.1016/j.jaci.2008.09.004. Epub 2008 Oct 10.
Reference Type
RESULT
Galant SP, Morphew T, Newcomb RL, Hioe K, Guijon O, Liao O. The relationship of the bronchodilator response phenotype to poor asthma control in children with normal spirometry. J Pediatr. 2011 Jun;158(6):953-959.e1. doi: 10.1016/j.jpeds.2010.11.029. Epub 2011 Jan 13.
Reference Type
RESULT
Naqvi M, Thyne S, Choudhry S, Tsai HJ, Navarro D, Castro RA, Nazario S, Rodriguez-Santana JR, Casal J, Torres A, Chapela R, Watson HG, Meade K, LeNoir M, Avila PC, Rodriguez-Cintron W, Burchard EG. Ethnic-specific differences in bronchodilator responsiveness among African Americans, Puerto Ricans, and Mexicans with asthma. J Asthma. 2007 Oct;44(8):639-48. doi: 10.1080/02770900701554441.
Reference Type
RESULT
Eigen H, Bieler H, Grant D, Christoph K, Terrill D, Heilman DK, Ambrosius WT, Tepper RS. Spirometric pulmonary function in healthy preschool children. Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):619-23. doi: 10.1164/ajrccm.163.3.2002054.
Reference Type
RESULT
Aurora P, Stocks J, Oliver C, Saunders C, Castle R, Chaziparasidis G, Bush A; London Cystic Fibrosis Collaboration. Quality control for spirometry in preschool children with and without lung disease. Am J Respir Crit Care Med. 2004 May 15;169(10):1152-9. doi: 10.1164/rccm.200310-1453OC. Epub 2004 Mar 17.
Reference Type
RESULT
American Thoracic Society; European Respiratory Society. ATS/ERS statement: raised volume forced expirations in infants: guidelines for current practice. Am J Respir Crit Care Med. 2005 Dec 1;172(11):1463-71. doi: 10.1164/rccm.200408-1141ST. No abstract available.
Reference Type
RESULT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MISP 40467
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma
NCT02360072
COMPLETED
Some Biomarkers in Bronchial Asthma in Children
NCT04175093
UNKNOWN
Study on Hospitalization of Children With Bronchial Asthma
NCT05800379
UNKNOWN
Prognosis and Influencing Factors of Asthma in Children Aged 5-12 Years
NCT05765383
UNKNOWN
Clinical Study on Chinese Children's Asthma Action Plan
NCT03435822
UNKNOWN
NA
Pediatric Asthma Control Under Community Management Model in China
NCT02649803
UNKNOWN
NA
Clinical Characteristics, Treatment and Prognosis of Chest Tightness Variant Asthma
NCT03237221
COMPLETED
Bronchoreversibility Test in Asthmatic Children and Correlation With Diagnostic Criteria Proposed by the GINA Guidelines
NCT03814018
COMPLETED
A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China
NCT06422663
COMPLETED
Longitudinal Assessment of Children With Severe Asthma and Severe Pre-school Wheeze
NCT01982162
COMPLETED
Asthma in Children
NCT01286532
COMPLETED
Investigation of Lung Ventilation Inhomogeneity in Pediatric Asthma
NCT01095354
COMPLETED
Experienced Chinese Herbal Formulas on Pediatric Asthma
NCT02341573
COMPLETED
NA
Telemedicine System and Intelligent Monitoring System Construction of Pediatric Asthma Based on the Electronic Stethoscope
NCT05659225
RECRUITING
NA
Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children
NCT00522782
COMPLETED
PHASE4
Coupled Inspiratory and Expiratory Muscle Training in Children With Bronchial Asthma
NCT05212558
COMPLETED
NA
A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
NCT06419413
RECRUITING
Effect of Bronchial Thermoplasty on Moderate Bronchial Asthma in China
NCT02965807
UNKNOWN
PHASE1/PHASE2
Childhood Asthma Management in Primary Care: Implementation Of Exhaled Nitric Oxide and Spirometry Testing
NCT02913872
COMPLETED
The Use of Inflammatory Markers to Guide Therapy in Children With Severe Asthma
NCT00262340
COMPLETED
NA
Evaluate the Therapeutic Effect of Inhaled Corticosteroid in Asthmatic Children
NCT03487809
RECRUITING
The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System
NCT07136025
RECRUITING
NA
Fluctuation of Airway Function in Children With Asthma
NCT02252289
COMPLETED
Level of FeNO in Chinese Asthma Patients
NCT04125316
COMPLETED